Synapse is an oral cognitive optimization protocol built around Dihexa, a synthetic peptide derived from angiotensin IV that crosses the blood-brain barrier to promote the formation of new synaptic connections
Meanwhile, Roche, Pfizer, AstraZeneca, Boehringer Ingelheim, and Amgen are pursuing them with different technologies such as oral small molecules, once-monthly administration, GLP-1/GIP, GLP-1/glucagon, and GIP receptor antagonism
Higher nicotine doses may increase side effects without clearly improving the thermogenic effect
By purchasing, you confirm products will be used strictly for research purposes only and in compliance with applicable laws and regulations
Community-reported research-peptide dosing typically uses 0.5-1 mg subcutaneous daily during loading (1-2 weeks), then 0.5-1 mg 2-3x weekly for maintenance
An economic analysis of hospital and dialysis modality costs associated with dialysis services in urban, rural and remote settings